Rolac 30 mg, a nonsteroidal anti-inflammatory drug (NSAID), is used for the short-term management of moderate to severe pain that requires analgesia at the opioid level.

Rolac is available in ampoules for I.M or I.V administration (Rolac 30 mg), and also in tablets for oral administration (Rolac 10 mg).

Each F.C Tablet of Rolac 10 mg contains Ketorolac tromethamine 10 mg.

Adults:

Rolac 10 mg is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.

The total combined duration of use of Rolac 10 mg must not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses.

children and adolescents

Do not give Rolac 10 mg to children less than 16 years of age and under 50 kg of weight.

Pregnancy&  breast-feeding:

Rolac 10 mg should not be used during pregnancy unless the expected benefit justifies the potential risk to the fetus. The lowest effective dose and shortest duration of treatment should be considered.

Pregnancy Category: C

Rolac 10 mg should not be used whilst breastfeeding because of potential adverse effects of prostaglandin-inhibiting drugs on neonates.

Adults:

The maximum daily dose of Rolac 10 mg must not be more than 40 mg in 24 hours.

The recommended dose of Rolac 10 mg in case of severe acute pain:

Either 20 mg once, then 10 mg every 8 hours per day.

Or 10 mg every 6 hours per day.

Children under 2 years:

Safety and efficacy not established

Children between 2 to 16 years (off label use):

Only I.V or I.M injection.